nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Delirium—Doxorubicin—sarcoma	0.00589	0.00589	CcSEcCtD
Zanamivir—Neutropenia—Etoposide—sarcoma	0.00573	0.00573	CcSEcCtD
Zanamivir—Musculoskeletal pain—Epirubicin—sarcoma	0.00554	0.00554	CcSEcCtD
Zanamivir—Ill-defined disorder—Dactinomycin—sarcoma	0.00547	0.00547	CcSEcCtD
Zanamivir—Agitation—Thiotepa—sarcoma	0.00546	0.00546	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00542	0.00542	CcSEcCtD
Zanamivir—Malaise—Dactinomycin—sarcoma	0.00532	0.00532	CcSEcCtD
Zanamivir—Influenza like illness—Epirubicin—sarcoma	0.00532	0.00532	CcSEcCtD
Zanamivir—Chills—Mitoxantrone—sarcoma	0.00529	0.00529	CcSEcCtD
Zanamivir—Arrhythmia—Mitoxantrone—sarcoma	0.00527	0.00527	CcSEcCtD
Zanamivir—Cough—Thiotepa—sarcoma	0.00519	0.00519	CcSEcCtD
Zanamivir—Convulsion—Thiotepa—sarcoma	0.00515	0.00515	CcSEcCtD
Zanamivir—Musculoskeletal pain—Doxorubicin—sarcoma	0.00513	0.00513	CcSEcCtD
Zanamivir—Arthralgia—Thiotepa—sarcoma	0.00506	0.00506	CcSEcCtD
Zanamivir—Myalgia—Thiotepa—sarcoma	0.00506	0.00506	CcSEcCtD
Zanamivir—Anxiety—Thiotepa—sarcoma	0.00504	0.00504	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00503	0.00503	CcSEcCtD
Zanamivir—Myalgia—Dactinomycin—sarcoma	0.00502	0.00502	CcSEcCtD
Zanamivir—Discomfort—Dactinomycin—sarcoma	0.00496	0.00496	CcSEcCtD
Zanamivir—Influenza like illness—Doxorubicin—sarcoma	0.00492	0.00492	CcSEcCtD
Zanamivir—Confusional state—Thiotepa—sarcoma	0.00489	0.00489	CcSEcCtD
Zanamivir—Agitation—Vincristine—sarcoma	0.00484	0.00484	CcSEcCtD
Zanamivir—Infection—Thiotepa—sarcoma	0.00482	0.00482	CcSEcCtD
Zanamivir—Infection—Dactinomycin—sarcoma	0.00478	0.00478	CcSEcCtD
Zanamivir—Ill-defined disorder—Mitoxantrone—sarcoma	0.00476	0.00476	CcSEcCtD
Zanamivir—Skin disorder—Thiotepa—sarcoma	0.00471	0.00471	CcSEcCtD
Zanamivir—Erythema multiforme—Etoposide—sarcoma	0.00464	0.00464	CcSEcCtD
Zanamivir—Malaise—Mitoxantrone—sarcoma	0.00463	0.00463	CcSEcCtD
Zanamivir—Anorexia—Thiotepa—sarcoma	0.00462	0.00462	CcSEcCtD
Zanamivir—Anorexia—Dactinomycin—sarcoma	0.00459	0.00459	CcSEcCtD
Zanamivir—Convulsion—Vincristine—sarcoma	0.00457	0.00457	CcSEcCtD
Zanamivir—Myalgia—Vincristine—sarcoma	0.00449	0.00449	CcSEcCtD
Zanamivir—Cough—Mitoxantrone—sarcoma	0.00448	0.00448	CcSEcCtD
Zanamivir—Convulsion—Mitoxantrone—sarcoma	0.00445	0.00445	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00442	0.00442	CcSEcCtD
Zanamivir—Chills—Etoposide—sarcoma	0.0044	0.0044	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00439	0.00439	CcSEcCtD
Zanamivir—Arthralgia—Mitoxantrone—sarcoma	0.00437	0.00437	CcSEcCtD
Zanamivir—Myalgia—Mitoxantrone—sarcoma	0.00437	0.00437	CcSEcCtD
Zanamivir—Anxiety—Mitoxantrone—sarcoma	0.00436	0.00436	CcSEcCtD
Zanamivir—Discomfort—Mitoxantrone—sarcoma	0.00432	0.00432	CcSEcCtD
Zanamivir—Anaphylactic shock—Vincristine—sarcoma	0.0043	0.0043	CcSEcCtD
Zanamivir—Infection—Vincristine—sarcoma	0.00427	0.00427	CcSEcCtD
Zanamivir—Increased appetite—Epirubicin—sarcoma	0.00423	0.00423	CcSEcCtD
Zanamivir—Confusional state—Mitoxantrone—sarcoma	0.00422	0.00422	CcSEcCtD
Zanamivir—Decreased appetite—Thiotepa—sarcoma	0.00422	0.00422	CcSEcCtD
Zanamivir—Anaphylactic shock—Mitoxantrone—sarcoma	0.00419	0.00419	CcSEcCtD
Zanamivir—Decreased appetite—Dactinomycin—sarcoma	0.00419	0.00419	CcSEcCtD
Zanamivir—Fatigue—Thiotepa—sarcoma	0.00418	0.00418	CcSEcCtD
Zanamivir—Infection—Mitoxantrone—sarcoma	0.00416	0.00416	CcSEcCtD
Zanamivir—Fatigue—Dactinomycin—sarcoma	0.00415	0.00415	CcSEcCtD
Zanamivir—Pain—Thiotepa—sarcoma	0.00415	0.00415	CcSEcCtD
Zanamivir—Shock—Mitoxantrone—sarcoma	0.00412	0.00412	CcSEcCtD
Zanamivir—Pain—Dactinomycin—sarcoma	0.00412	0.00412	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Epirubicin—sarcoma	0.00411	0.00411	CcSEcCtD
Zanamivir—Anorexia—Vincristine—sarcoma	0.0041	0.0041	CcSEcCtD
Zanamivir—Skin disorder—Mitoxantrone—sarcoma	0.00407	0.00407	CcSEcCtD
Zanamivir—Feeling abnormal—Thiotepa—sarcoma	0.004	0.004	CcSEcCtD
Zanamivir—Anorexia—Mitoxantrone—sarcoma	0.00399	0.00399	CcSEcCtD
Zanamivir—Feeling abnormal—Dactinomycin—sarcoma	0.00397	0.00397	CcSEcCtD
Zanamivir—Gastrointestinal pain—Thiotepa—sarcoma	0.00397	0.00397	CcSEcCtD
Zanamivir—Ill-defined disorder—Etoposide—sarcoma	0.00396	0.00396	CcSEcCtD
Zanamivir—Gastrointestinal pain—Dactinomycin—sarcoma	0.00394	0.00394	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Vincristine—sarcoma	0.00392	0.00392	CcSEcCtD
Zanamivir—Increased appetite—Doxorubicin—sarcoma	0.00391	0.00391	CcSEcCtD
Zanamivir—Urticaria—Thiotepa—sarcoma	0.00385	0.00385	CcSEcCtD
Zanamivir—Malaise—Etoposide—sarcoma	0.00385	0.00385	CcSEcCtD
Zanamivir—Face oedema—Epirubicin—sarcoma	0.00384	0.00384	CcSEcCtD
Zanamivir—Abdominal pain—Thiotepa—sarcoma	0.00384	0.00384	CcSEcCtD
Zanamivir—Body temperature increased—Thiotepa—sarcoma	0.00384	0.00384	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00382	0.00382	CcSEcCtD
Zanamivir—Abdominal pain—Dactinomycin—sarcoma	0.00381	0.00381	CcSEcCtD
Zanamivir—Body temperature increased—Dactinomycin—sarcoma	0.00381	0.00381	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Doxorubicin—sarcoma	0.0038	0.0038	CcSEcCtD
Zanamivir—Loss of consciousness—Etoposide—sarcoma	0.00375	0.00375	CcSEcCtD
Zanamivir—Decreased appetite—Vincristine—sarcoma	0.00374	0.00374	CcSEcCtD
Zanamivir—Dyspnoea—Mitoxantrone—sarcoma	0.00374	0.00374	CcSEcCtD
Zanamivir—Cough—Etoposide—sarcoma	0.00373	0.00373	CcSEcCtD
Zanamivir—Fatigue—Vincristine—sarcoma	0.00371	0.00371	CcSEcCtD
Zanamivir—Convulsion—Etoposide—sarcoma	0.0037	0.0037	CcSEcCtD
Zanamivir—Dehydration—Epirubicin—sarcoma	0.0037	0.0037	CcSEcCtD
Zanamivir—Pain—Vincristine—sarcoma	0.00368	0.00368	CcSEcCtD
Zanamivir—Decreased appetite—Mitoxantrone—sarcoma	0.00364	0.00364	CcSEcCtD
Zanamivir—Fatigue—Mitoxantrone—sarcoma	0.00361	0.00361	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00361	0.00361	CcSEcCtD
Zanamivir—Discomfort—Etoposide—sarcoma	0.00359	0.00359	CcSEcCtD
Zanamivir—Pain—Mitoxantrone—sarcoma	0.00358	0.00358	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00358	0.00358	CcSEcCtD
Zanamivir—Hypersensitivity—Thiotepa—sarcoma	0.00357	0.00357	CcSEcCtD
Zanamivir—Face oedema—Doxorubicin—sarcoma	0.00355	0.00355	CcSEcCtD
Zanamivir—Hypersensitivity—Dactinomycin—sarcoma	0.00355	0.00355	CcSEcCtD
Zanamivir—Gastrointestinal pain—Vincristine—sarcoma	0.00352	0.00352	CcSEcCtD
Zanamivir—Confusional state—Etoposide—sarcoma	0.00351	0.00351	CcSEcCtD
Zanamivir—Anaphylactic shock—Etoposide—sarcoma	0.00349	0.00349	CcSEcCtD
Zanamivir—Asthenia—Thiotepa—sarcoma	0.00348	0.00348	CcSEcCtD
Zanamivir—Infection—Etoposide—sarcoma	0.00346	0.00346	CcSEcCtD
Zanamivir—Asthenia—Dactinomycin—sarcoma	0.00345	0.00345	CcSEcCtD
Zanamivir—Feeling abnormal—Mitoxantrone—sarcoma	0.00345	0.00345	CcSEcCtD
Zanamivir—Influenza—Epirubicin—sarcoma	0.00344	0.00344	CcSEcCtD
Zanamivir—Asthma—Epirubicin—sarcoma	0.00344	0.00344	CcSEcCtD
Zanamivir—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00343	0.00343	CcSEcCtD
Zanamivir—Dehydration—Doxorubicin—sarcoma	0.00342	0.00342	CcSEcCtD
Zanamivir—Abdominal pain—Vincristine—sarcoma	0.0034	0.0034	CcSEcCtD
Zanamivir—Body temperature increased—Vincristine—sarcoma	0.0034	0.0034	CcSEcCtD
Zanamivir—Skin disorder—Etoposide—sarcoma	0.00339	0.00339	CcSEcCtD
Zanamivir—Urticaria—Mitoxantrone—sarcoma	0.00333	0.00333	CcSEcCtD
Zanamivir—Anorexia—Etoposide—sarcoma	0.00332	0.00332	CcSEcCtD
Zanamivir—Diarrhoea—Thiotepa—sarcoma	0.00332	0.00332	CcSEcCtD
Zanamivir—Body temperature increased—Mitoxantrone—sarcoma	0.00331	0.00331	CcSEcCtD
Zanamivir—Abdominal pain—Mitoxantrone—sarcoma	0.00331	0.00331	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00331	0.00331	CcSEcCtD
Zanamivir—Bronchitis—Epirubicin—sarcoma	0.0033	0.0033	CcSEcCtD
Zanamivir—Diarrhoea—Dactinomycin—sarcoma	0.00329	0.00329	CcSEcCtD
Zanamivir—Neutropenia—Epirubicin—sarcoma	0.00321	0.00321	CcSEcCtD
Zanamivir—Dizziness—Thiotepa—sarcoma	0.00321	0.00321	CcSEcCtD
Zanamivir—Influenza—Doxorubicin—sarcoma	0.00318	0.00318	CcSEcCtD
Zanamivir—Asthma—Doxorubicin—sarcoma	0.00318	0.00318	CcSEcCtD
Zanamivir—Hypersensitivity—Vincristine—sarcoma	0.00317	0.00317	CcSEcCtD
Zanamivir—Dyspnoea—Etoposide—sarcoma	0.00311	0.00311	CcSEcCtD
Zanamivir—Hypersensitivity—Mitoxantrone—sarcoma	0.00309	0.00309	CcSEcCtD
Zanamivir—Asthenia—Vincristine—sarcoma	0.00309	0.00309	CcSEcCtD
Zanamivir—Vomiting—Thiotepa—sarcoma	0.00308	0.00308	CcSEcCtD
Zanamivir—Vomiting—Dactinomycin—sarcoma	0.00306	0.00306	CcSEcCtD
Zanamivir—Rash—Thiotepa—sarcoma	0.00306	0.00306	CcSEcCtD
Zanamivir—Bronchitis—Doxorubicin—sarcoma	0.00306	0.00306	CcSEcCtD
Zanamivir—Dermatitis—Thiotepa—sarcoma	0.00306	0.00306	CcSEcCtD
Zanamivir—Headache—Thiotepa—sarcoma	0.00304	0.00304	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00304	0.00304	CcSEcCtD
Zanamivir—Rash—Dactinomycin—sarcoma	0.00304	0.00304	CcSEcCtD
Zanamivir—Decreased appetite—Etoposide—sarcoma	0.00303	0.00303	CcSEcCtD
Zanamivir—Asthenia—Mitoxantrone—sarcoma	0.00301	0.00301	CcSEcCtD
Zanamivir—Fatigue—Etoposide—sarcoma	0.003	0.003	CcSEcCtD
Zanamivir—Pain—Etoposide—sarcoma	0.00298	0.00298	CcSEcCtD
Zanamivir—Neutropenia—Doxorubicin—sarcoma	0.00297	0.00297	CcSEcCtD
Zanamivir—Diarrhoea—Vincristine—sarcoma	0.00294	0.00294	CcSEcCtD
Zanamivir—Nausea—Thiotepa—sarcoma	0.00288	0.00288	CcSEcCtD
Zanamivir—Sinusitis—Epirubicin—sarcoma	0.00287	0.00287	CcSEcCtD
Zanamivir—Feeling abnormal—Etoposide—sarcoma	0.00287	0.00287	CcSEcCtD
Zanamivir—Diarrhoea—Mitoxantrone—sarcoma	0.00287	0.00287	CcSEcCtD
Zanamivir—Nausea—Dactinomycin—sarcoma	0.00286	0.00286	CcSEcCtD
Zanamivir—Gastrointestinal pain—Etoposide—sarcoma	0.00285	0.00285	CcSEcCtD
Zanamivir—Dizziness—Vincristine—sarcoma	0.00284	0.00284	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00281	0.00281	CcSEcCtD
Zanamivir—Urticaria—Etoposide—sarcoma	0.00277	0.00277	CcSEcCtD
Zanamivir—Haemoglobin—Epirubicin—sarcoma	0.00276	0.00276	CcSEcCtD
Zanamivir—Abdominal pain—Etoposide—sarcoma	0.00276	0.00276	CcSEcCtD
Zanamivir—Body temperature increased—Etoposide—sarcoma	0.00276	0.00276	CcSEcCtD
Zanamivir—Haemorrhage—Epirubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Zanamivir—Vomiting—Vincristine—sarcoma	0.00274	0.00274	CcSEcCtD
Zanamivir—Rash—Vincristine—sarcoma	0.00271	0.00271	CcSEcCtD
Zanamivir—Dermatitis—Vincristine—sarcoma	0.00271	0.00271	CcSEcCtD
Zanamivir—Headache—Vincristine—sarcoma	0.0027	0.0027	CcSEcCtD
Zanamivir—Vomiting—Mitoxantrone—sarcoma	0.00266	0.00266	CcSEcCtD
Zanamivir—Sinusitis—Doxorubicin—sarcoma	0.00266	0.00266	CcSEcCtD
Zanamivir—Rash—Mitoxantrone—sarcoma	0.00264	0.00264	CcSEcCtD
Zanamivir—Dermatitis—Mitoxantrone—sarcoma	0.00264	0.00264	CcSEcCtD
Zanamivir—Headache—Mitoxantrone—sarcoma	0.00262	0.00262	CcSEcCtD
Zanamivir—Erythema multiforme—Epirubicin—sarcoma	0.0026	0.0026	CcSEcCtD
Zanamivir—Hypersensitivity—Etoposide—sarcoma	0.00257	0.00257	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—sarcoma	0.00256	0.00256	CcSEcCtD
Zanamivir—Nausea—Vincristine—sarcoma	0.00256	0.00256	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—sarcoma	0.00254	0.00254	CcSEcCtD
Zanamivir—Asthenia—Etoposide—sarcoma	0.0025	0.0025	CcSEcCtD
Zanamivir—Nausea—Mitoxantrone—sarcoma	0.00249	0.00249	CcSEcCtD
Zanamivir—Chills—Epirubicin—sarcoma	0.00247	0.00247	CcSEcCtD
Zanamivir—Arrhythmia—Epirubicin—sarcoma	0.00246	0.00246	CcSEcCtD
Zanamivir—Erythema multiforme—Doxorubicin—sarcoma	0.00241	0.00241	CcSEcCtD
Zanamivir—Diarrhoea—Etoposide—sarcoma	0.00238	0.00238	CcSEcCtD
Zanamivir—Dizziness—Etoposide—sarcoma	0.0023	0.0023	CcSEcCtD
Zanamivir—Chills—Doxorubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Zanamivir—Arrhythmia—Doxorubicin—sarcoma	0.00227	0.00227	CcSEcCtD
Zanamivir—Ill-defined disorder—Epirubicin—sarcoma	0.00222	0.00222	CcSEcCtD
Zanamivir—Vomiting—Etoposide—sarcoma	0.00222	0.00222	CcSEcCtD
Zanamivir—Agitation—Epirubicin—sarcoma	0.0022	0.0022	CcSEcCtD
Zanamivir—Rash—Etoposide—sarcoma	0.0022	0.0022	CcSEcCtD
Zanamivir—Dermatitis—Etoposide—sarcoma	0.0022	0.0022	CcSEcCtD
Zanamivir—Headache—Etoposide—sarcoma	0.00218	0.00218	CcSEcCtD
Zanamivir—Malaise—Epirubicin—sarcoma	0.00216	0.00216	CcSEcCtD
Zanamivir—Syncope—Epirubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Zanamivir—Loss of consciousness—Epirubicin—sarcoma	0.0021	0.0021	CcSEcCtD
Zanamivir—Cough—Epirubicin—sarcoma	0.00209	0.00209	CcSEcCtD
Zanamivir—Convulsion—Epirubicin—sarcoma	0.00207	0.00207	CcSEcCtD
Zanamivir—Nausea—Etoposide—sarcoma	0.00207	0.00207	CcSEcCtD
Zanamivir—Ill-defined disorder—Doxorubicin—sarcoma	0.00206	0.00206	CcSEcCtD
Zanamivir—Myalgia—Epirubicin—sarcoma	0.00204	0.00204	CcSEcCtD
Zanamivir—Arthralgia—Epirubicin—sarcoma	0.00204	0.00204	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—sarcoma	0.00204	0.00204	CcSEcCtD
Zanamivir—Anxiety—Epirubicin—sarcoma	0.00203	0.00203	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00202	0.00202	CcSEcCtD
Zanamivir—Discomfort—Epirubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—sarcoma	0.002	0.002	CcSEcCtD
Zanamivir—Syncope—Doxorubicin—sarcoma	0.00199	0.00199	CcSEcCtD
Zanamivir—Confusional state—Epirubicin—sarcoma	0.00197	0.00197	CcSEcCtD
Zanamivir—Anaphylactic shock—Epirubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Zanamivir—Loss of consciousness—Doxorubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Zanamivir—Infection—Epirubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Zanamivir—Cough—Doxorubicin—sarcoma	0.00193	0.00193	CcSEcCtD
Zanamivir—Shock—Epirubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Zanamivir—Skin disorder—Epirubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Zanamivir—Anorexia—Epirubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Zanamivir—Infection—Doxorubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Zanamivir—Shock—Doxorubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Zanamivir—Skin disorder—Doxorubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Zanamivir—Dyspnoea—Epirubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Zanamivir—Anorexia—Doxorubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Zanamivir—Decreased appetite—Epirubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Zanamivir—Fatigue—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Zanamivir—Pain—Epirubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Zanamivir—Dyspnoea—Doxorubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Zanamivir—Feeling abnormal—Epirubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Zanamivir—Gastrointestinal pain—Epirubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Zanamivir—Decreased appetite—Doxorubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Zanamivir—Urticaria—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Zanamivir—Pain—Doxorubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Zanamivir—Abdominal pain—Epirubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Zanamivir—Body temperature increased—Epirubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Zanamivir—Gastrointestinal pain—Doxorubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Zanamivir—Hypersensitivity—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Zanamivir—Urticaria—Doxorubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Zanamivir—Asthenia—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Zanamivir—Diarrhoea—Epirubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Zanamivir—Hypersensitivity—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Zanamivir—Dizziness—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Zanamivir—Vomiting—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Zanamivir—Rash—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Zanamivir—Dermatitis—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Zanamivir—Headache—Epirubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Zanamivir—Dizziness—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Zanamivir—Nausea—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Zanamivir—Vomiting—Doxorubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Zanamivir—Rash—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Zanamivir—Headache—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
